Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inje CYP probe cocktail pharmacokinetic study in severe COPD
ACTRN12619000861156Phase 4Terminated
- Sponsor
- Dr Richard McNeill
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of midazolam, dextromethorphan, losartan, omeprazole, caffeine and 1 more in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Dr Richard McNeill. Primary endpoints: Area under the plasma concentration-time curve of midazolam, Area under the plasma concentration-time curve of dextromethorphan and 1 more. Started Aug 2019; status: terminated.
02
Drugs
midazolamdextromethorphanlosartanomeprazolecaffeine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ACTRN12619000861156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000861156.